Christopher G. Lafarge

Mr. LaFarge is an operationally focused director and executive, with extensive experience as a senior executive in closely held companies including entrepreneurial start-ups, high-growth, and mature organizations. He has also served on the Boards of several privately held corporations, as well as educational and non-profit boards.

He has acquired deep experience in the areas of product development, life sciences, QA systems, and financing. An energetic and outgoing executive who understands business issues and focuses on leading by building relationships and collaborating at all levels.

Mr. LaFarge has provided strategic leadership for early stage, life science, and medical device companies in the fields of urology, anesthesiology, intensive care, and neuroscience as well as companies in the oil and gas, management consulting, and natural resources industries. He has significant experience in raising both debt and equity capital.

Since 2019, Mr. LaFarge has been the COO of Bach Pharma, a pharmaceutical company developing therapeutics for the treatment of neurodegenerative diseases like ALS and Parkinson’s and other life-threatening redox and inflammation-related illnesses like radiation, chemical poisoning, or viral and bacterial infections like pneumonia.

Christopher is also working with an artificial intelligence company in Atlanta GA, IMARC AI, to develop AI-based decision support for ICU/ER physicians as well as other healthcare AI applications.

From 2004-2018, He was the President and CEO of MedicaMetrix, Inc., the predecessor organization to MedicaMetrix LLC where he invented ProstaMetric®, obtained European regulatory approval (CE Marking certification), and created scalable, manufacturing procedures for the device, and developed a quality management system which received an ISO 13485 certification.

From 1994-2003 he was the CFO and Director of Business Development for IIC, which was created to build and market expert systems, intelligent devices, and control systems for the exploration, drilling, and production segments of the “upstream” petroleum industry.

Christopher also has a wide range of Board experience, working as part of both management teams and boards as well as start-ups and recently capitalized companies with newly organized boards. Mr. LaFarge has an MBA from the Yale School of Management, an MFS in environmental Science from Yale U., and a BA in Biology from Harvard College.